Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features.
about
Clinical review: Vasculitis on the intensive care unit--part 1: diagnosisRecent advances in anti-neutrophil cytoplasmic antibody-associated vasculitisEnzyme-labeled Antigen Method: Development and Application of the Novel Approach for Identifying Plasma Cells Locally Producing Disease-specific Antibodies in Inflammatory LesionsBench-to-bedside review: Pulmonary–renal syndromes – an update for the intensivistAntineutrophil cytoplasmic antibody frequency in chronic hepatitis B patients.Simultaneous automated screening and confirmatory testing for vasculitis-specific ANCA.Clinical aspects of primary vasculitis.Testing for antineutrophil cytoplasmic antibodies.Antineutrophil cytoplasmic autoantibody in the absence of Wegener's granulomatosis or microscopic polyangiitis: implications for the surgical pathologist.Pulmonary renal syndrome in a child with coexistence of anti-neutrophil cytoplasmic antibodies and anti-glomerular basement membrane disease: case report and literature review.[Medium and large vessel vasculitis].Antineutrophil cytoplasmic antibodies testing in a large cohort of unselected greek patients.The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies.Protein microarrays: a new tool for the study of autoantibodies in immunodeficiencyHydralazine-induced ANCA-positive pauci-immune glomerulonephritis: a case report and literature review.An approach to the diagnosis and management of systemic vasculitis.Antineutrophil cytoplasmic antibody (ANCA)-positive cutaneous leukocytoclastic vasculitis induced by propylthiouracil confirmed by positive patch test: a case report and review of the literature.B-cell therapy in antineutrophil cytoplasmic antibody-associated vasculitis.Clinical aspects of indirect immunofluorescence for autoimmune diseases.Value of non-identified ANCA (non-PR3, non-MPO) in the diagnosis of granulomatosis with polyangiitis (Wegener's granulomatosis).Automated indirect immunofluorescence evaluation of antinuclear autoantibodies on HEp-2 cellsGranulomatosis with Polyangiitis (Wegener's Granulomatosis) Accompanied by Dysuria.POEMS syndrome with renal plasmacytoma and classic polyarteritis nodosa: a case report.Simultaneous comprehensive multiplex autoantibody analysis for rapidly progressive glomerulonephritisMarked improvement in renal function after rectal cancer resection in a case of anti-neutrophil cytoplasmic autoantibody-negative pauci-immune crescentic glomerulonephritis.Audit of the clinical usefulness of a rapid qualitative ELISA screen for antimyeloperoxidase and antiproteinase 3 antibodies in the assessment of patients with suspected vasculitis.Immunofluorescent patterns produced by antineutrophil cytoplasmic antibodies (ANCA) vary depending on neutrophil substrate and conjugate.Onset of Microscopic Polyangiitis in Binephrectomied Patient on Chronic Hemodialysis-Case Report.Demographics and environmental factors in a Wegener's granulomatosis cluster.Levamisole-Induced ANCA Vasculitis and Cutaneous Necrosis.Rational requesting or rationing testing?Relationship between anti-neutrophil cytoplasmic antibody determined with conventional binding and the capture assay, and long-term clinical course in vasculitis.Antineutrophil cytoplasmic antibodies induce decreased CD62L expression and enhanced metabolic activity in monocytes.The prevalence and target antigens of antithyroid drugs induced antineutrophil cytoplasmic antibodies (ANCA) in Chinese patients with hyperthyroidism.ANCA-negative pauci-immune renal vasculitis: histology and outcome.Discrepancies between two immunoassays for the determination of MPO and PR3 autoantibodies.Granulomatosis With Polyangiitis-Associated Hypertrophic Pachymeningitis Mimicking Spontaneous Intracranial Hypotension: A Case Report.PR3 antibodies do not induce renal pathology in a novel PR3-humanized mouse model for Wegener’s granulomatosisUnklare Hepatitis mit protrahiertem Leberversagen bei einem 48-jährigen Patienten mit deutlich erhöhtem pANCA-Titer
P2860
Q24802072-DB3EC645-6AE3-468D-9823-647E31578C64Q26751357-50B7227B-51F8-4ABD-8AF7-A8B1FFAC55DAQ26752509-23929A44-7DC4-4BC2-8A42-125D2C600F79Q27485164-7924AC02-1907-45EA-A4B0-1163F3441621Q34069405-34400A61-AD7E-4798-89AF-80867C200E34Q34199391-50ACEC9A-AFF9-4F7D-AB04-FE510AC48E6DQ34395162-358D6469-D32D-40E6-BF38-C09D8C8C078BQ34569292-A4883710-67FF-432E-BB40-168CEDF0A6C1Q34571110-0414D195-636A-4261-B84D-60833FF38C5FQ34631010-B0F29520-5596-44F5-AB74-885BB86497AAQ34976638-DEA548E3-6582-41E5-9CCB-CCDD35984A7EQ35038822-571132B7-2514-4C59-AD55-9B29E874D7B2Q35084923-8C483F3E-27CF-421A-9925-7BCD27A2B6FCQ35296572-491841AD-AE8F-4E1A-BB2C-A73A8CF9C3D2Q37611024-F45CCEAD-50E9-4966-B459-3D28580BD8D9Q37673239-7AE6BF57-94A4-45A4-91F4-964E5C0651FFQ37811004-1C5863CF-5F4B-45AE-9883-59F026A84949Q38371009-72487DB6-0764-4BA6-9C35-D7C50BF26C28Q38382986-B0D51759-EB2C-43BC-AE5D-B1644B38ED81Q39032392-63337E81-09A5-4050-85C8-A922AC231264Q39224111-B8F6CDB0-15DC-4EE0-93F0-B12C41DD5DB8Q39528437-9584C10F-80BE-475C-85BD-1B0AFB03B76CQ40337657-16092B43-2948-4621-92B7-D76DF77B9DD4Q40446804-BE6E5CF6-6903-4048-915E-160EAEB7E3CDQ41086477-AD140AFF-6CD4-4FF5-B557-B619163D96CEQ42019441-8759DBF2-F9FC-4241-86A9-51A9AA4C2FB4Q42173432-2758E1F0-9E74-4F6B-BF64-9044979445B8Q42322160-C5E8FC6E-C0AC-48F4-A548-5851BC199A02Q42955077-B77A9019-7977-49EE-A0BE-403DFE0DC489Q42956326-F68ECC9B-2AE8-4BD6-B76D-DBFAE7D74F5CQ43010830-FA1CC749-A265-4B48-A9FC-85CA92F92A14Q43924598-91AE4570-B604-49F8-B67F-7996F252135BQ44316844-61A6595C-3E19-4FAC-A0AE-24C89CD405FDQ45097310-2359BAB2-888B-4BF8-9D94-2BF0CE8D23B0Q46458557-C2CFEB7E-008D-435E-9CC6-92FE0766F0BCQ50879150-8B2ABD89-8842-401B-9742-01A0460215FAQ51081668-C91762EC-5007-4405-8AC6-158EDBB6510AQ56967056-4B93BEF8-E0AC-4572-B95E-ECED3D5E36F7Q57920391-36D14DBF-CDA1-47D8-A77B-03249EFC02FF
P2860
Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Antineutrophil cytoplasmic ant ...... nical and laboratory features.
@ast
Antineutrophil cytoplasmic ant ...... nical and laboratory features.
@en
type
label
Antineutrophil cytoplasmic ant ...... nical and laboratory features.
@ast
Antineutrophil cytoplasmic ant ...... nical and laboratory features.
@en
prefLabel
Antineutrophil cytoplasmic ant ...... nical and laboratory features.
@ast
Antineutrophil cytoplasmic ant ...... nical and laboratory features.
@en
P2093
P1433
P1476
Antineutrophil cytoplasmic ant ...... nical and laboratory features.
@en
P2093
P304
P356
10.1046/J.1523-1755.2000.057003846.X
P407
P577
2000-03-01T00:00:00Z
P5875
P6179
1024429652